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Abstract
 
In murine 
 
Schistosoma mansoni
 
 infections, schistosome-specific cross-reactive idiotypes (CRI) are
present in the sera of mice with moderate splenomegaly syndrome (MSS) at 20 wk after infec-
tion. In contrast, sera from animals that have the more severe hypersplenomegaly syndrome
(HSS) at 20 wk of infection do not express these CRI in their sera. To examine when these reg-
ulatory CRI first appear in mice that eventually develop MSS, sera from infected animals were
monitored for CRI from 1.5 to 20 wk of infection. In mice that eventually developed MSS,
CRI were detected by 5 to 6 wk after infection, plateaued by 8 to 10 wk, and persisted through
20 wk of infection. Animals that developed HSS pathology or that died before 20 wk of infec-
tion never expressed CRI. Moreover, CRI levels present in the sera of mice at 6 wk of infec-
tion were inversely correlated with splenomegaly and hepatic fibrosis, but not with parasitologic
measures, at 20 wk after infection. These results suggest that critical events occur very early in
some schistosome infections that induce the production of regulatory idiotypes and that the
presence or absence of these idiotypes predicts, and possibly determines, subsequent morbidity.
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Introduction
 
The pathology caused by 
 
Schistosoma mansoni
 
 infections re-
sults from granulomatous inflammation surrounding para-
site eggs in the liver that can lead to periportal fibrosis.
Many of the eggs released by adult female worms living in
the mesenteric venules of infected hosts beginning 5 to 6
wk after infection are swept by the portal circulation to
the liver where they become lodged in the presinusoidal
capillaries and invoke an intense immunologic response.
The acute phase of schistosomiasis occurs at 8 wk after in-
fection when the magnitude of this granulomatous re-
sponse peaks. The disease subsequently enters the chronic
phase and the intensity of inflammation in response to
newly deposited eggs gradually decreases (1). Current hy-
potheses suggest that failure to appropriately modulate the
immune responses associated with granuloma formation af-
ter the acute phase of infection results in the increased fi-
brosis, portal hypertension, and spleen enlargement ob-
served in humans with severe hepatosplenic schistosomiasis
(2, 3). Most investigations into the mechanics of immuno-
modulation in experimental schistosomiasis have focused
on the cell subsets and cytokines involved in granuloma
formation in the acute and chronic phases of infection (4–8).
However, we have also presented strong evidence sug-
gesting that idiotypic interactions also play an important
immunoregulatory role in experimental and human schis-
tosomiasis, perhaps functioning through some of the afore-
 
mentioned mechanisms, such as differential cytokine induction
(9–13). Others have reported similar immunoregulatory
idiotypic interactions in 
 
Schistosoma japonicum
 
 infections
(14–16).
Affinity purified, anti-schistosome soluble egg antigen
(SEA)
 
 
 
antibodies prepared from sera of patients with the
asymptomatic chronic (“intestinal”) form of schistosomiasis
and 20 wk infected mice with the analogous moderate
splenomegaly syndrome (MSS) contain a population of id-
iotypes (Id) that stimulate proliferation of PBMCs and
spleen cells from infected humans and mice, respectively
(9, 11). Studies on spleen cells from infected mice have also
shown that Id prepared from the sera of MSS mice (MSS
Id) stimulates production of IFN-
 
 
 
, a cytokine that regu-
lates granuloma formation (11, 17–19). Rabbit antibodies
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raised against Id prepared from the sera of patients with in-
testinal schistosomiasis cross reacts with MSS Id, suggesting
certain stimulatory idiotopes are shared across species (10,
20), i.e., are cross-reactive Id (CRI). In contrast, patients
with severe hepatosplenic disease and 20 wk–infected mice
with the analogous hypersplenomegaly syndrome (HSS)
fail to express CRI and antibodies prepared from their sera
do not stimulate cellular proliferation or cytokine produc-
tion (9–11). The association of CRI with less severe pa-
thology combined with the ability of CRI to stimulate
production of granuloma-inhibiting cytokines suggested
that they may play an important role in regulating the pa-
thology of chronic schistosomiasis.
Further support for this hypothesis came from studies in
which neonatal mice were injected with CRI, allowed to
mature to adulthood, and infected with 
 
S. mansoni
 
. Mice
exposed to preparations containing CRI (MSS Id or Id
prepared from sera of mice infected for 8 wk) demonstrated
prolonged survival, smaller granulomas, decreased fibrosis,
and enhanced IFN-
 
 
 
 production compared with animals
that were neonatally injected with CRI-negative prepara-
tions (affinity-purified anti-SEA antibodies prepared from
the sera of HSS mice or commercially procured normal
mouse immunoglobulin; reference 12). The immunologic
effects of neonatal CRI exposure were also investigated by
evaluating SEA-induced responses in mice neonatally in-
jected with CRI but that received no exposure to 
 
S. man-
soni
 
 antigens or infection. As adults, these mice displayed
significant SEA-induced spleen cell proliferation, Th1 cy-
tokine responses, and serum IgG while animals neonatally
injected with HSS Id or normal mouse immunoglobulin
lacked these SEA-related responses (13). Whether mice
that were neonatally injected with CRI were infected with
 
S. mansoni
 
 or not, their sera as adults contained CRI and
anti-CRI, suggesting that neonatal exposure led to the es-
tablishment of an idiotypic network with immunoregula-
tory properties (13, and unpublished data). We have previ-
ously shown that serum CRI begins to appear by 6 wk of
 
S. mansoni
 
 infection (21) but those studies did not docu-
ment their presence in relationship to eventual clinical out-
comes at chronicity.
Because our previous findings suggested a link between
serum CRI and decreased schistosomiasis-associated pa-
thology in both humans and mice, we more precisely iden-
tified the time points at which regulatory CRIs are first ex-
pressed during schistosome infections of mice. In addition,
we examined whether the presence or absence of CRI
early in infection could predict the pathologic outcome of
chronic schistosomiasis in a given mouse or group of mice
before 20 wk of infection. We also investigated the rela-
tionship between CRI levels and parameters associated
with schistosomiasis morbidity, such as splenomegaly, he-
patic hydroxyproline levels, and infection intensity.
 
Materials and Methods
 
Mice.
 
Male CBA/J mice were obtained from The Jackson
Laboratory and housed in the Association for Assessment and
 
Accreditation of Laboratory Animal Care–approved facilities of
the Centers for Disease Control and Prevention. The mice were
infected by subcutaneous injection with 45 cercariae of a Puerto
Rican strain of 
 
S. mansoni
 
 that had been maintained in
 
Biomphalaria glabrata
 
 snails. Individual mice were tracked by the
use of transponders (Bio Medic Data Systems, Inc.). Blood
(
 
 
 
100 
 
 
 
l) was obtained by retroorbital puncture from anesthe-
tized animals at designated weeks after infection. Mice surviving
until 20 wk of infection were weighed, killed by CO
 
2
 
 inhala-
tion, and exsanguinated by cardiac puncture. Spleens and livers
were removed and weighed portions (
 
 
 
0.5 g) of liver were fro-
zen at 
 
 
 
80
 
 
 
C until analysis for egg and hydroxyproline content
were performed.
 
Enumeration of Eggs and Hydroxyproline Levels in the Liver.
 
Liver tissue that had been collected for egg enumeration was
placed in 5 ml of 5% KOH at 37
 
 
 
C for 2 to 4 h until the diges-
tion was complete (22). Duplicate 25-
 
 
 
l aliquots of the digest
were placed on a glass slide, and eggs were counted under a mi-
croscope. The number of eggs per gram of liver tissue was calcu-
lated for each animal.
Hepatic collagen content was determined by measuring hy-
droxyproline levels in liver hydrolysates. The protocol (23, 24)
was modified for microplate analysis and used as an estimate of
liver fibrosis. Briefly, weighed liver samples were hydrolyzed in 5
ml of 6 M HCl for 18 h at 110
 
 
 
C in glass tubes, after which 40
mg Dowex/Norit mixture (Sigma-Aldrich) and 5 ml distilled
water were added to each hydrolysate. The mixture was centri-
fuged for 15 min at 2,000 rpm at 25
 
 
 
C, and the supernatant fluid
filtered through filter paper into a clean tube. 2 ml of the filtrate
was neutralized by adding one drop of 1% phenophthalein and
then titrated against 10 M NaOH until colorless. The final vol-
ume was adjusted to 4 ml. A small aliquot (12.5 
 
 
 
l) of neutralized
liver hydrolysate was pipetted into each well of a microtiter plate
and mixed with 25 
 
 
 
l isopropanol. Freshly prepared oxidant so-
lution (chloramine-T/citrate buffer, pH 6.0; Sigma-Aldrich) was
added (12.5 
 
 
 
l) into each well with mixing and then incubated at
25
 
 
 
C for 4 min. Freshly prepared Ehrlich’s Reagent Solution
(150 
 
 
 
l; Sigma-Aldrich) was added, mixed, and incubated at
60
 
 
 
C for an additional 25 min. The plate was allowed to cool and
the absorbance read at 570 nm using a microplate reader (Molec-
ular Devices). Hydroxyproline levels were calculated against stan-
dard curves of 4-hydroxy-L-proline (Calbiochem) and expressed
as 
 
 
 
g hydroxyproline/g tissue.
 
SEA and Id Preparation.
 
SEA was prepared as described pre-
viously (25). Briefly, eggs were isolated by differential centrifuga-
tion from homogenized liver tissue of CF-1 mice (Charles Rivers
Laboratories) infected with 300 cercariae for 7 to 8 wk. Soluble
material from purified eggs was obtained by homogenization in
Dulbecco’s PBS and subsequent ultracentrifugation. To prepare
affinity-purified, polyclonal anti-SEA Abs that expressed CRI
(MSS Id), pooled sera from 20 wk infected MSS (10) mice were
passed over a column of SEA coupled to cyanogen-bromide-acti-
vated Sepharose 4B (Sigma-Aldrich). Bound anti-SEA Abs (Id)
were eluted using 0.1 M glycine-HCl (pH 2.8) and collected into
0.025 M borax. The eluates were concentrated and dialyzed
against saline, and their protein concentrations were determined.
 
Rabbit Anti-CRI Production and Competitive ELISA for CRI Lev-
els.
 
Rabbit anti-Id was prepared by immunizing a rabbit (Myr-
tle’s Rabbitry) subcutaneously and intramuscularly with 200 
 
 
 
g
MSS Id preparation mixed 1:1 in RIBI adjuvant (RIBI Immu-
noChem Research). Three injections were given at 15-d inter-
vals. 15 d after the final injection, the rabbit was bled. Ig was pu-
rified from the rabbit serum using a T-Gel purification Kit 
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(Pierce Chemical Co.). Id-specific antiserum was prepared by ex-
haustively absorbing the immunized rabbit serum with normal
mouse immunoglobulin (Sigma-Aldrich) coupled to cyanogen
bromide–activated Sepharose 4B (10 mg Ig/g Sepharose). Re-
peated absorptions (between 15 and 20) yielded reagent which
did not react with normal mouse immunoglobulin while reactiv-
ity with the original immunizing MSS Id preparation was main-
tained. The competitive ELISA using this reagent to measure se-
rum CRI levels has been described previously (9).
 
Statistical Analyses.
 
Statistical analyses were performed using
GraphPad Instat (GraphPad Software).
 
Results and Discussion
 
At 20 wk after infection with 
 
S. mansoni
 
, sera from mice
with MSS contain CRI but sera from mice with HSS do
not (10, 11). To determine when regulatory CRI first ap-
pears in mice that eventually develop MSS, individual in-
fected mice were followed over 20 wk and bled at different
times during their infections. Animals that survived until 20
wk were killed and classified as MSS or HSS according to
their spleen to body weight ratio and gross pathologic char-
acteristics (10). Serum CRI levels were determined by
competitive ELISA using anti-MSS Id rabbit serum and an
MSS Id standard curve. Fig. 1 shows the results from three
different longitudinal experimental infections. In mice that
eventually developed MSS by 20 wk of infection, serum
CRI could be detected as early as 5 or 6 wk after infection.
Serum CRI levels in these mice rose rapidly by 8 to 10 wk
after infection and continued to increase through 20 wk of
infection. In contrast, mice that displayed HSS at 20 wk af-
ter infection or mice that died before 20 wk expressed little
to no detectable CRI in their sera at any time during their
infection. Mice that died before 20 wk of infection and
were autopsied had characteristics similar to those of mice
with HSS at 20 wk of infection: they were anemic, devoid
of fat, and had obvious ascites.
Although we have reported that CRI can be detected
early in 
 
S. mansoni
 
 infections (21), our previous longitudi-
nal studies of MSS and HSS mice suggested that differences
between pathologic groups occurred later in infection as
significant differences between anemia and serum triglycer-
ide levels in mice that develop these distinct pathologies are
not detected until 10 and 14 wk after infection, respec-
tively (26). The current data indicate that the immunobio-
logic processes that determine whether or not experimental
animals in this model develop severe pathology are in place
very early in infection, concurrent with worm maturation
and egg production. If this is true, it might be expected that
the presence or absence of CRI at 6 wk after infection
should be predictive of whether mice will eventually de-
velop MSS or HSS. Regression analyses of individual mice
confirmed this and demonstrated significant correlations
between CRI levels at 6 wk of infection and spleen percent
body weight ratios at 20 wk of infection (Fig. 2).
In addition to splenomegaly, in one experiment (corre-
sponding to the bottom panel from Figs. 1 and 2) we also
evaluated the relationship between early CRI production
and liver hydroxyproline levels later in infection (Fig. 3).
Again, high CRI levels at 6 wk of infection correlated with
low hepatic fibrosis and low CRI was associated with in-
creased pathology at 20 wk of infection. We also evaluated
the relationship between early CRI and measures of the in-
Figure 1. Longitudinal profile of serum CRI levels in S. mansoni in-
fected mice. Groups of 30 to 40 CBA/J mice were infected with 45 cer-
cariae of S. mansoni. Mice were bled at the indicated weeks and serum
CRI levels were determined by competitive ELISA. At 20 wk after infec-
tion, surviving animals were killed and classified as MSS or HSS accord-
ing to the percentage of spleen to body weight ratios. Sera from mice that
died before 20 wk of infection were also tested for the weeks they were
bled before their deaths. Each panel represents an independent experi-
ment. The status at 20 wk after infection is indicated in the key for each
experiment, and the final number of mice is shown in parentheses. 
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tensity of infection. There was no significant relationship
between 6 wk CRI levels and the number of eggs in the
liver (
 
r
 
 
 
 
 
 
 
 
 
0.2765, 
 
P
 
 
 
 
 
 0.4105) or circulating adult worm
cathodic antigen levels (
 
r
 
 
 
 
 
 
 
 
 
0.3325, 
 
P
 
 
 
 
 
 0.3177) at 20
wk of infection (data not shown). These findings corrobo-
rated our previous studies demonstrating that severe pa-
thology is not merely a function of increased worm burden
(10, 12, 26).
We believe that the strong correlation between early
CRI levels and chronic pathology represents a cause and
effect of CRI on pathology rather than a simple association
 
of both measures with some other immunologic measure.
This belief is bolstered by our previous findings that a sin-
gle neonatal injection of mice with CRI leads to high levels
of CRI and anti-CRI in the sera of these mice when they
become adults and confers humoral and cellular reactivity
to schistosome antigens that they have never encountered
(13). If these mice are subsequently infected with schisto-
somes, the animals that received CRI as neonates demon-
strate increased IFN-
 
 
 
 production, decreased granuloma
size and fibrosis, and increased survival compared with ani-
mals that received control immunoglobulin or an Id prepa-
ration lacking CRI activity (12). Other studies have simi-
larly demonstrated an important role for antibodies and
their Fc receptors in modulation of the granulomatous re-
sponse (27–30).
The finding that CRI levels early in infection predict
chronic pathology is very exciting. We hope to employ this
tool to evaluate the dynamic changes that occur in the pro-
gression to severe or nonsevere chronic schistosomiasis,
identify what immunologic manipulations (in addition to
neonatal Id injection) we can employ before or during in-
fection to shift mice toward less severe disease, and perhaps
identify which schistosome antigen(s) and/or epitope(s) are
important for generation of CRI. It also has the potential
for important public health applications. Because mice and
humans with low morbidity share idiotopes and display the
same pattern of CRI expression during chronic infections,
absence of CRI production in humans who have schistoso-
miasis may be a useful predictor for patients likely to de-
velop hepatosplenic disease. Those individuals could be fol-
lowed more closely for infection and treated more
aggressively than is currently indicated in general schistoso-
miasis control programs. We hope to verify whether the
correlation of serum CRI with low pathology in experi-
mental animals is also true for humans by comparing
patients’ serum CRI levels with their pattern of hepatic fi-
brosis detected by ultrasound. We anticipate that schisto-
some-positive persons with even low levels of fibrosis will
Figure 2. CRI levels at 6 wk of infection predict splenomegaly at 20
wk. Correlation analysis between a mouse’s serum CRI at 6 wk after in-
fection and the same animal’s spleen percent body weight at 20 wk after
infection. Each panel represents an independent experiment correspond-
ing to the experiments in Fig. 1.
Figure 3. Relationships between serum levels of CRI at 6 wk of infec-
tion and hepatic hydroxyproline at 20 wk of infection. 
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have decreased levels of serum CRI compared with schisto-
somiasis patients with no detectable hepatic pathology. If this
expectation is borne out by clinical studies, we may well be
able to develop powerful tools for identifying and preventing
severe disease in persons with 
 
S. mansoni
 
 infections.
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